Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis

References

• Ross R, Epstein FH. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340(2):115–126. doi:10.1056/NEJM199901143400207
   PubMed Web of Science ®Google Scholar
• Bansilal S, Castellano JM, Fuster V. Global burden of CVD: focus on secondary prevention of cardiovascular disease. Int J Cardiol. 2015;201:S1–S7. doi:10.1016/S0167-5273(15)31026-3
   PubMed Web of Science ®Google Scholar
• Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535–546. doi:10.1161/CIRCRESAHA.115.307611
   PubMed Web of Science ®Google Scholar
• Yan R, Li W, Yin L, et al. Cardiovascular diseases and risk‐factor burden in urban and rural communities in high‐, middle‐, and low‐income regions of china: a large community‐based epidemiological study. J Am Heart Assoc. 2017;6(2). doi:10.1161/JAHA.116.004445
   Web of Science ®Google Scholar
• Xi B, Liu F, Hao Y, Dong H, Mi J. The growing burden of cardiovascular diseases in China. Int J Cardiol. 2014;174(3):736–737. doi:10.1016/j.ijcard.2014.04.098
   PubMed Web of Science ®Google Scholar
• Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015. doi:10.1016/S0140-6736(13)61097-1
   PubMed Web of Science ®Google Scholar
• Gimbrone MA, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620–636. doi:10.1161/CIRCRESAHA.115.306301
   PubMed Web of Science ®Google Scholar
• Ali L, Schnitzler JG, Kroon J. Metabolism. Curr Opin Lipidol. 2018;29(6):474–480. doi:10.1097/MOL.0000000000000550
   PubMed Web of Science ®Google Scholar
• Brown RA, Shantsila E, Varma C, Lip GYH. Current understanding of atherogenesis. Am J Med. 2017;130(3):268–282. doi:10.1016/j.amjmed.2016.10.022
   PubMed Web of Science ®Google Scholar
• He B, Nie Q, Wang F, et al. Role of pyroptosis in atherosclerosis and its therapeutic implications. J Cell Physiol. 2021;236(10):7159–7175. doi:10.1002/jcp.30366
   PubMed Web of Science ®Google Scholar
• Jia C, Chen H, Zhang J, et al. Role of pyroptosis in cardiovascular diseases. Int Immunopharmacol. 2019;67:311–318. doi:10.1016/j.intimp.2018.12.028
   PubMed Web of Science ®Google Scholar
• Zhaolin Z, Guohua L, Shiyuan W, Zuo W. Role of pyroptosis in cardiovascular disease. Cell Prolif. 2019;52(2):e12563. doi:10.1111/cpr.12563
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–254. doi:10.1016/j.tibs.2016.10.004
   PubMed Web of Science ®Google Scholar
• Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM. Emerging activators and regulators of inflammasomes and pyroptosis. Trends Immunol. 2019;40(11):1035–1052. doi:10.1016/j.it.2019.09.005
   PubMed Web of Science ®Google Scholar
• Vande Walle L, Lamkanfi M. Pyroptosis. Curr Biol. 2016;26(13):R568–R572. doi:10.1016/j.cub.2016.02.019
   PubMed Web of Science ®Google Scholar
• Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018;233(3):2116–2132. doi:10.1002/jcp.25930
   PubMed Web of Science ®Google Scholar
• Bai B, Yang Y, Wang Q, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11(9):776. doi:10.1038/s41419-020-02985-x
   PubMed Web of Science ®Google Scholar
• Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–1361. doi:10.1038/nature08938
   PubMed Web of Science ®Google Scholar
• Christ A, Günther P, Lauterbach MAR, et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell. 2018;172(1–2):162–175.e14. doi:10.1016/j.cell.2017.12.013
   PubMed Web of Science ®Google Scholar
• He X, Fan X, Bai B, Lu N, Zhang S, Zhang L. Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis. Pharmacol Res. 2021;165:105447. doi:10.1016/j.phrs.2021.105447
   PubMed Web of Science ®Google Scholar
• Xu YJ, Zheng L, Hu YW, Wang Q. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta. 2018;476:28–37. doi:10.1016/j.cca.2017.11.005
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002
   PubMed Web of Science ®Google Scholar
• Jin H, Ko YS, Park SW, Kim HJ. P2Y2R activation by ATP induces oxLDL-mediated inflammasome activation through modulation of mitochondrial damage in human endothelial cells. Free Radic Biol Med. 2019;136:109–117. doi:10.1016/j.freeradbiomed.2019.04.004
   PubMed Web of Science ®Google Scholar
• Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221–225. doi:10.1038/nature09663
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang D, Hu D, Zhou X, Zhou Y. The role of mitochondria in NLRP3 inflammasome activation. Mol Immunol. 2018;103:115–124. doi:10.1016/j.molimm.2018.09.010
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121–135. doi:10.1038/nrm.2017.95
   PubMed Web of Science ®Google Scholar
• Gao F, Chen J, Zhu H. A potential strategy for treating atherosclerosis: improving endothelial function via AMP-activated protein kinase. Sci China Life Sci. 2018;61(9):1024–1029. doi:10.1007/s11427-017-9285-1
   PubMed Web of Science ®Google Scholar
• Tian L, Cao W, Yue R, et al. Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway. J Pharmacol Sci. 2019;139(4):352–360. doi:10.1016/j.jphs.2019.02.008
   PubMed Web of Science ®Google Scholar
• Su X, Yao Z, Li S, Sun H. Synergism of Chinese herbal medicine: illustrated by Danshen compound. Evid Based Complement Altern Med. 2016;2016:1–10. doi:10.1155/2016/7279361
   Web of Science ®Google Scholar
• Wu TW, Zeng LH, Fung KP, et al. Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem Pharmacol. 1993;46(12):2327–2332. doi:10.1016/0006-2952(93)90624-6
   PubMed Web of Science ®Google Scholar
• Xu H, Ji Chen K. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chin J Integr Med. 2011;17(2):83–84. doi:10.1007/s11655-011-0641-2
   PubMed Web of Science ®Google Scholar
• Shang Q, Xu H, Huang L. Tanshinone IIA: a promising natural cardioprotective agent. Evid Based Complement Altern Med. 2012;2012:1–7. doi:10.1155/2012/716459
   Web of Science ®Google Scholar
• Zhang D, Lu X, He S, et al. Sodium tanshinone IIA sulfonate protects against Aβ‐induced cell toxicity through regulating Aβ process. J Cell Mol Med. 2020;24(6):3328–3335. doi:10.1111/jcmm.15006
   PubMed Web of Science ®Google Scholar
• Chen L, He W, Peng B, et al. Sodium Tanshinone IIA sulfonate improves post-ischemic angiogenesis in hyperglycemia. Biochem Biophys Res Commun. 2019;520(3):580–585. doi:10.1016/j.bbrc.2019.09.106
   PubMed Web of Science ®Google Scholar
• Zhou X, Pan Y, Wang Y, et al. Tanshinones induce tumor cell apoptosis via directly targeting FHIT. Sci Rep. 2021;11(1):12217. doi:10.1038/s41598-021-91708-z
   PubMed Web of Science ®Google Scholar
• Cheng Y, An Q, Wang J, Wang Y, Dong J, Yin J. RasGRF1 participates in the protective effect of tanshinone IIA on depressive like behaviors of a chronic unpredictable mild stress induced mouse model. Gene. 2020;754:144817. doi:10.1016/j.gene.2020.144817
   PubMed Web of Science ®Google Scholar
• Yang N, Chen H, Gao Y, et al. Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis. Biomed Pharmacother. 2020;132:110815. doi:10.1016/j.biopha.2020.110815
   PubMed Web of Science ®Google Scholar
• Yang G, Jia L, Wu J, et al. Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver. Exp Ther Med. 2017. doi:10.3892/etm.2017.5162
   Web of Science ®Google Scholar
• Wang N, Zhang X, Ma Z, et al. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling. Biomed Pharmacother. 2020;123:109729. doi:10.1016/j.biopha.2019.109729
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen Z, Ma Z, et al. Tanshinone IIA protects endothelial cells from H 2 O 2 -induced injuries via PXR activation. Biomol Ther. 2017;25(6):599–608. doi:10.4062/biomolther.2016.179
   PubMed Web of Science ®Google Scholar
• Zhu J, Xu Y, Ren G, et al. Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol. 2017;815:427–436. doi:10.1016/j.ejphar.2017.09.047
   PubMed Web of Science ®Google Scholar
• Qun Jia L, Lin Yang G, Ren L, et al. Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells. J Ethnopharmacol. 2012;143(1):100–108. doi:10.1016/j.jep.2012.06.007
   PubMed Web of Science ®Google Scholar
• He L, Liu YY, Wang K, et al. Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway. Biochem Biophys Res Commun. 2021;575:1–7. doi:10.1016/j.bbrc.2021.08.067
   PubMed Web of Science ®Google Scholar
• Chen HW, Yen CC, Kuo LL, et al. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells. Toxicol Appl Pharmacol. 2020;393:114941. doi:10.1016/j.taap.2020.114941
   PubMed Web of Science ®Google Scholar
• Rajamäki K, Lappalainen J, Öörni K, et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One. 2010;5(7):e11765. doi:10.1371/journal.pone.0011765
   PubMed Web of Science ®Google Scholar
• Ma X, Lu D, Liu Y, et al. Multiplexed quantitative evaluation on mitochondrial toxicity of tris (2,3-dibromopropyl) phosphate in hepatocyte. Ecotoxicol Environ Saf. 2021;221:112425. doi:10.1016/j.ecoenv.2021.112425
   PubMed Web of Science ®Google Scholar
• Le Y, Shen H, Yang Z, Lu D, Wang C. Comprehensive analysis of organophosphorus flame retardant-induced mitochondrial abnormalities: potential role in lipid accumulation. Environ Pollut. 2021;274:116541. doi:10.1016/j.envpol.2021.116541
   PubMed Web of Science ®Google Scholar
• Liu X, Xu Y, Cheng S, et al. Geniposide combined with notoginsenoside R1 attenuates inflammation and apoptosis in atherosclerosis via the AMPK/mTOR/Nrf2 signaling pathway. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.687394
   Web of Science ®Google Scholar
• Xie T, Wang C, Jin Y, et al. CoenzymeQ10-induced activation of AMPK-YAP-OPA1 pathway alleviates atherosclerosis by improving mitochondrial function, inhibiting oxidative stress and promoting energy metabolism. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.01034
   Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167–1174. doi:10.1172/JCI13505
   PubMed Web of Science ®Google Scholar
• Ming Li Z, Wen Xu S, Qing Liu P. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39(5):802–824. doi:10.1038/aps.2017.193
   PubMed Web of Science ®Google Scholar
• Amaya-Montoya M, Pinzón-Cortés JA, Silva-Bermúdez LS, et al. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity. Lipids Health Dis. 2020;19(1):106. doi:10.1186/s12944-020-01291-x
   PubMed Web of Science ®Google Scholar
• Li YH, Tseng WK, Yin WH, et al. Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment. Sci Rep. 2020;10(1):21835. doi:10.1038/s41598-020-78828-8
   PubMed Web of Science ®Google Scholar
• Khera AV, Demler OV, Adelman SJ, et al. Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events. Circulation. 2017;135(25):2494–2504. doi:10.1161/CIRCULATIONAHA.116.025678
   PubMed Web of Science ®Google Scholar
• Qian Z, Zhao Y, Wan C, et al. Pyroptosis in the initiation and progression of atherosclerosis. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.652963
   Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi:10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi J, Shao F. Inflammatory caspases: activation and cleavage of gasdermin-D in vitro and during pyroptosis. Methods Mol Biol. 2018;131–148. doi:10.1007/978-1-4939-7519-8_9
   PubMedGoogle Scholar
• Yang M, Lv H, Liu Q, et al. Colchicine alleviates cholesterol crystal-induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway. Oxid Med Cell Longev. 2020;2020:1–18. doi:10.1155/2020/9173530
   Web of Science ®Google Scholar
• Abdul-Muneer PM, Alikunju S, Mishra V, et al. Activation of NLRP3 inflammasome by cholesterol crystals in alcohol consumption induces atherosclerotic lesions. Brain Behav Immun. 2017;62:291–305. doi:10.1016/j.bbi.2017.02.014
   PubMed Web of Science ®Google Scholar
• Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85–100. doi:10.1038/s41580-019-0173-8
   PubMed Web of Science ®Google Scholar
• Qi D, Young LH. AMPK: energy sensor and survival mechanism in the ischemic heart. Trends Endocrinol Metab. 2015;26(8):422–429. doi:10.1016/j.tem.2015.05.010
   PubMed Web of Science ®Google Scholar
• Wu S, Zou MH. AMPK, mitochondrial function, and cardiovascular disease. Int J Mol Sci. 2020;21(14):4987. doi:10.3390/ijms21144987
   PubMed Web of Science ®Google Scholar